» Articles » PMID: 26027937

Microwave Ablation Compared to Radiofrequency Ablation for Hepatic Lesions: A Meta-Analysis

Overview
Date 2015 Jun 2
PMID 26027937
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the efficacy and safety of microwave (MW) ablation compared with radiofrequency (RF) ablation for hepatic lesions by using meta-analytic techniques. Overall, 16 studies involving 2,062 patients were included. MW ablation was found to have significantly better 6-year overall survival than RF ablation (odds ratio, 1.64, 95% confidence interval, 1.15-2.35), but this was based on a few articles (n = 3 of 16). MW ablation and RF ablation had similar 1-5-year overall survival, disease-free survival, local recurrence rate, and adverse events. Based on similar safety and efficacy outcomes, either MW ablation or RF ablation may be used for effective local hepatic therapy.

Citing Articles

Microwave coagulation for liver metastases.

Storman D, Swierz M, Mitus J, Pedziwiatr M, Liang N, Wolff R Cochrane Database Syst Rev. 2024; 3:CD010163.

PMID: 38534000 PMC: 10966940. DOI: 10.1002/14651858.CD010163.pub3.


Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases.

Serenari M, Ratti F, Stocco A, De Cobelli F, Serra C, Santangelo D Surg Endosc. 2024; 38(5):2611-2621.

PMID: 38499784 DOI: 10.1007/s00464-024-10757-3.


Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.

Zensen S, Bucker A, Meetschen M, Haubold J, Opitz M, Theysohn J Eur Radiol. 2023; 34(5):3322-3330.

PMID: 37935847 PMC: 11126481. DOI: 10.1007/s00330-023-10412-w.


The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes.

Koza A, Bhogal R, Fotiadis N, Mavroeidis V Biomedicines. 2023; 11(4).

PMID: 37189680 PMC: 10135821. DOI: 10.3390/biomedicines11041062.


Percutaneous ablation for adrenal metastases: a systematic review and meta-analysis.

Zhang J, Fu Y, Wang J Wideochir Inne Tech Maloinwazyjne. 2023; 17(4):549-560.

PMID: 36818506 PMC: 9909773. DOI: 10.5114/wiitm.2022.119585.